There are really two separate results in the trial on INV102. Firstly there is the result expressed in the number of cigarettes smoked at end trial, drug versus placebo. Then there are the results on sputum samples for which we have preliminary results in, I think January. These relate to the inhaled programme and the capacity for the drug to heal the lung. We should see something on the three of these this week, or at least by mid August.
IVX Price at posting:
2.6¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)